Chase Williams

Chase Williams has extensive experience in the pharmaceutical industry, having held senior roles at Gilead Sciences from January 2020 to December 2022, including Senior Director of Medical Key Accounts and Principal Medical Value and Evidence Liaison. Williams has provided scientific evidence and clinical data to various stakeholders across a diverse portfolio, including Oncology, HIV, and Hepatitis. Prior experience includes roles as Medical Science Liaison for Renal Cardio at AstraZeneca and for Obesity at Novo Nordisk, as well as Specialty Area Business Leader for Diabetes and Sr. Pharmacy Account Specialist at Sanofi. Williams started a career as a Pharmacist at Walmart. Educational qualifications include an MBA in Finance from Loyola University Chicago and a Master of Science in Marketing from the University of Illinois Chicago.